What Novo Nordisk, OpenAI and Pop Mart have in common
All three have suffered the curse of overnight success
EVERY chief executive dreams of it: a product so successful that it propels their company from obscurity to superstardom seemingly overnight.
Among the lessons from 2025, however, is that runaway success is not all upside. As the experience of whizzy chatbots, weight-loss jabs and wacky dolls illustrates, it brings problems, too.
The first pitfall is that bosses face the vexed task of scaling up their business to satisfy a level of demand that is impossible to predict.
TRENDING NOW
Father-and-son duo Raj Kumar and Kishin in exclusive due diligence to buy Scotts Square
When every phone becomes a satellite phone, what happens to Asia’s telcos?
Koh Brothers Eco Engineering faces up to S$57.6 million in potential legal liabilities
Too little, too late? Manila’s billion-dollar bid to ignite its sputtering EV industry